Genotyping of Marcoux et al.’s cohort showed also significant incidence of TP53- and RB1-mutations in the LACs before undergoing SCLC-transformation and after having transformed as well as in the de novo EGFRM+ SCLC specimens [195]. Here, TP53 is linked to small cell lung carcinoma.